B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

HISTONE-LYSINE

MOLECULAR TARGET

Histone-lysine N-methyltransferase NSD2 (human)

UniProt: O96028175 compounds

HISTONE-LYSINE (Histone-lysine N-methyltransferase NSD2 (human)) is targeted by 175 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting HISTONE-LYSINE

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Dasatinib2.087
2Axitinib1.956
3Azathioprine1.956
4Bortezomib1.956
5Crizotinib1.956
6Disulfiram1.956
7Ouabain1.956
8Chlorhexidine1.795
9Methylene Blue1.614
10ag4901.614
11alpelisib1.614
12Methotrexate1.614
13Calcitriol1.614
14Clofarabine1.614
15Colchicine1.614
16cycloheximide1.614
17Decitabine1.614
18Deferasirox1.614
19deguelin [Supplementary Concept]1.614
20Digitoxin1.614
21Digoxin1.614
22Emetine1.614
23Gemcitabine1.614
24Leflunomide1.614
25Maprotiline1.614
26Melphalan1.614
27monorden1.614
28Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of1.614
29Nocodazole Nocodazole is1.614
30pictilisib1.614
31Podophyllotoxin1.614
32Proscillaridin1.614
33Sorafenib1.614
34sp6001251.614
35Thapsigargin1.614
36torin 11.614
37trichostatic acid [Supplementary Concept] related to trichostatin1.614
38Trifluridine1.614
39Tripterygium1.614
40vinblastine sulfate1.614
41Vincristine1.614
42withaferin1.614
43Daunorubicin1.393
44Dexrazoxane1.393
45Ethinyl Estradiol1.393
46Lovastatin1.393
47Luteolin 5,7,3',4'-tetrahydroxy-flavone,1.102
48Prednisolone1.102
49Quercetin1.102
50Sertraline1.102

Showing top 50 of 175 compounds. Use the BiohacksAI search to explore all HISTONE-LYSINE modulators.

About HISTONE-LYSINE as a Drug Target

HISTONE-LYSINE (Histone-lysine N-methyltransferase NSD2 (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 175 compounds with documented HISTONE-LYSINE interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

HISTONE-LYSINE inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.